Glycemic Control in the ICU

Advances in Surgery

Volumn 42, Issue C, 2008, Pages 261-275

  Bochicchio, Grant V ^a   Scalea, Thomas M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

BLOOD; CRITICAL ILLNESS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE UNIT; METABOLISM; PATHOPHYSIOLOGY; REVIEW; STRESS;

BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; INTENSIVE CARE UNITS; STRESS;

EID: 49849099640     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2008.03.006     Document Type: Review

References (66)

1. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
2. Mizock B.A. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15 (2001) 533-551
3. Klip A., Tsakiridis T., Marette A., et al. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 8 (1994) 43-53
4. Turina M., Christ-Crain M., and Polk Jr. H.C. Diabetes and hyperglycemia: strict glycemic control. Crit Care Med 34 (2006) S291-S300
5. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycemia. Crit Care Clin 17 (2001) 107-124
6. Mizock B.A. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 98 (1995) 75-84
7. Clerici C., and Matthay M.A. Hypoxia regulates gene expression of alveolar epithelial transport proteins. J Appl Physiol 88 (2000) 1890-1896
8. Pekala P., Marlow M., Heuvelman D., et al. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 265 (1990) 18051-18054
9. Sanchez-Alvarez R., Tabernero A., and Medina J.M. Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. J Neurochem 89 (2004) 703-714
10. Rolih C.A., and Ober K.P. The endocrine response to critical illness. Med Clin North Am 79 (1995) 211-224
11. Wolfe R.R. Herman Award Lecture, 1996: relation of metabolic studies to clinical nutrition-the example of burn injury. Am J Clin Nutr 64 (1996) 800-808
12. Bastard J.P., Maachi M., Van Nhieu J.T., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87 (2002) 2084-2089
13. Borst S.E. The role of TNF-alpha in insulin resistance. Endocrine 23 (2004) 177-182
14. Rotter V., Nagaev I., and Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278 (2003) 45777-45784
15. Borst S.E., Lee Y., Conover C.F., et al. Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue. Am J Physiol Endocrinol Metab 287 (2004) E934-E938
16. Cheung A.T., Wang J., Ree D., et al. Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes 49 (2000) 810-819
17. Ma Y., Toth B., Keeton A.B., et al. Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha. Endocrinology 145 (2004) 5168-5176
18. Bessey P.Q., Brooks D.C., Black P.R., et al. Epinephrine acutely mediates skeletal muscle insulin resistance. Surgery 94 (1983) 172-179
19. James D.E., Burleigh K.M., and Kraegen E.W. In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin. J Biol Chem 261 (1986) 6366-6374
20. Smith T.R., Elmendorf J.S., David T.S., et al. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Am J Physiol 272 (1997) E1071-E1079
21. Venkatesan N., Lim J., Bouch C., et al. Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. Metabolism 45 (1996) 92-100
22. Vanhorebeek I., De V.R., Mesotten D., et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
23. Boger R.H., Maas R., Schulze F., et al. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chem Lab Med 43 (2005) 1124-1129
24. Siroen M.P., van Leeuwen P.A., Nijveldt R.J., et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?. Crit Care Med 33 (2005) 504-510
25. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 (2005) 2277-2286
26. Khaodhiar L., McCowen K., and Bistrian B. Perioperative hyperglycemia, infection or risk?. Curr Opin Clin Nutr Metab Care 2 (1999) 79-82
27. Marfella R., Nappo F., De A.L., et al. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 43 (2000) 571-575
28. Perner A., Nielsen S.E., and Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 29 (2003) 642-645
29. Turina M., Fry D.E., and Polk Jr. H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 33 (2005) 1624-1633
30. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
31. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32 (2001) 2426-2432
32. Norhammar A.M., Ryden L., and Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 22 (1999) 1827-1831
33. Zindrou D., Taylor K.M., and Bagger J.P. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care 24 (2001) 1634-1639
34. Umpierrez G.E., Isaacs S.D., Bazargan N., et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87 (2002) 978-982
35. Vincent J.L., Abraham E., Annane D., et al. Reducing mortality in sepsis: new directions. Crit Care 6 Suppl 3 (2002) S1-S18
36. Pittas A.G., Siegel R.D., and Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 164 (2004) 2005-2011
37. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
38. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
39. Bochicchio G.V., Sung J., Joshi M., et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 58 (2005) 921-924
40. Bochicchio G.V., Salzano L., Joshi M., et al. Admission preoperative glucose is predictive of morbidity and mortality in trauma patients who require immediate operative intervention. Am Surg 71 (2005) 171-174
41. Bruno A., Levine S.R., Frankel M.R., et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59 (2002) 669-674
42. Fraker D.L., Merino M.J., and Norton J.A. Reversal of the toxic effects of cachectin by concurrent insulin administration. Am J Physiol 256 (1989) E725-E731
43. Hotamisligil G.S., and Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43 (1994) 1271-1278
44. Kotari G., Usami M., Kasaharo H., et al. The relationship of IL-6 to hormonal mediators for utilization and systemic hypermetabolism after surgical trauma. Kobe Journal of Medical Science 42 (Abstract) (1996) 187
45. Laird A.M., Miller P.R., Kilgo P.D., et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 56 (2004) 1058-1062
46. Satomi N., Sakurai A., and Haranaka K. Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages. J Natl Cancer Inst 74 (1985) 1255-1260
47. Sung J., Bochicchio G.V., Joshi M., et al. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 59 (2005) 80-83
48. Yendamuri S., Fulda G.J., and Tinkoff G.H. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 55 (2003) 33-38
49. Bochicchio G.V., Joshi M., Bochicchio K.M., et al. Early hyperglycemic control is important in critically injured trauma patients. J Trauma 63 (2007) 1353-1358
50. Turina M., Miller F.N., Tucker C.F., et al. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg 243 (2006) 845-851
51. Scalea T.M., Bochicchio G.V., Bochicchio K.M., et al. Tight glycemic control in critically injured trauma patients. Ann Surg 246 (2007) 605-610
52. Finney S.J., Zekveld C., Elia A., et al. Glucose control and mortality in critically ill patients. JAMA 290 (2003) 2041-2047
53. Gabbanelli V., Pantanetti S., Donati A., et al. Correlation between hyperglycemia and mortality in a medical and surgical intensive care unit. Minerva Anestesiol 71 (2005) 717-725
54. Ouattara A., Lecomte P., Le M.Y., et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103 (2005) 687-694
55. Angus D.C., and Abraham E. Intensive insulin therapy in critical illness. Am J Respir Crit Care Med 172 (2005) 1358-1359
56. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 (2008) 125-139
57. Devos P., Ledoux D., and Preiser J.C. Current practice of glycaemia control in European intensive care units (ICUs): The GLUCONTROL Steering Committee. Intensive Care Medicine 31 (Abstract) (2005) 130
58. McMullin J., Brozek J., Jaeschke R., et al. Glycemic control in the ICU: a multicenter survey. Intensive Care Med 30 (2004) 798-803
59. Egi M., Bellomo R., Stachowski E., et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105 (2006) 244-252
60. Bochicchio G.V., Joshi M., Bochicchio K., et al. Early hyperglycemic control is important in critically injured trauma patients. J Trauma 63 6 (2007) 1358-1359
61. Boord J.B., Graber A.L., Christman J.W., et al. Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med 164 (2001) 1763-1767
62. Gerich J.E., Mokan M., Veneman T., et al. Hypoglycemia unawareness. Endocr Rev 12 (1991) 356-371
63. Krinsley J.S., and Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 35 (2007) 2262-2267
64. Vriesendorp T.M., van S.S., DeVries J.H., et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 34 (2006) 96-101
65. Van den Berghe G. Saving lives with insulin in the ICU. Int J Obes Relat Metab Disord 26 (2002) S3-S8
66. Goldberg P.A., Siegel M.D., Sherwin R.S., et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27 (2004) 461-467